Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer

Author： Qu Yiqing  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.27, Iss.4, 2010-12, pp. : 1303-1308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer - report of a phase I/II dose-escalating study

By Thomas A.L.   Cox G.   Sharma R.A.   Steward W.P.   Shields F.   Jeyapalan K.   Muller S.   O'Byrne K.J.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2329-2334

Elsevier

Access to resources Recommend Favorite

Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer

By Baron F.   Cueva J.   Grana B.   Curiel T.   Leon L.   Vazquez F.   Candamio S.   Lopez R.  

European Journal of Cancer, Vol. 37, Iss. 11, 2001-07 ,pp. : 1381-1384

Elsevier

Access to resources Recommend Favorite

Effects of Gemcitabine on renal function in patients with non-small cell lung cancer

By Gietema J.A.   Groen H.J.M.   Meijer S.   Smit E.F.  

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 199-202

Elsevier

Access to resources Recommend Favorite

Methylation profiling in non-small cell lung cancer: Clinical implications

By                      

International Journal of Oncology, Vol. 40, Iss. 3, 2012-01 ,pp. : 739-746

Spandidos Publications

Access to resources Recommend Favorite

Critical contribution of MCL-1 in EMT-associated chemo-resistance in A549 non-small cell lung cancer

By                  

International Journal of Oncology, Vol. 46, Iss. 4, 2015-01 ,pp. : 1844-1848

Spandidos Publications

Access to resources Recommend Favorite